El riesgo, especialmente en personas con diabetes que toman otros medicamentos para bajar la glucosa en sangre, es que el paciente pueda presentar un episodio de hipoglucemia , advierte Christian Hcht, profesor titular de la Ctedra de Farmacologa de la Facultad de Farmacia y Bioqumica de la Universidad de Buenos Aires
A: Often, yeswith medical oversight
its a science-backed approach designed to support sustainable, long-term results
When systemic oxidative stress is highas it is in Long COVID and ME/CFSit significantly lowers the activation threshold of mast cells, making them incredibly trigger-happy
Coverage for off-label uses, including weight loss, is unlikely
Disclaimer: This article is for informational purposes only and is not a substitute for medical advice